GLP-2 Tirz 10mg: Dual-Incretin Receptor Agonist

Tirzepatide (brand names Mounjaro and Zepbound) is a dual-incretin agonist that targets both Glucose-dependent Insulinotropic Polypeptide (GIP) and Glucagon-Like Peptide-1 (GLP-1) receptors. It is not a GLP-2 drug. At a 10mg weekly dosage, it significantly lowers blood glucose, delays gastric emptying, and increases satiety